Phase 4 Gastroparesis Trial, Recruiting NCT07254715 Sponsor: Ain Shams University Condition: Gastroparesis
Back to Gastroparesis

Phase 4 Gastroparesis Trial, Recruiting

NCT07254715
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been assessed by a doctor as being in generally good to moderate health for anaesthesia (classified as ASA grade I, II, or III — confirm with trial site if unsure which applies to you)
  • You are between 40 and 60 years old
  • Your body mass index (BMI) is between 20 and 30
  • You have diabetes and are currently taking a weekly semaglutide injection (0.5mg or 1mg dose) under the skin
  • You are scheduled for a planned (non-emergency) hysterectomy (surgical removal of the womb)

Who may not be able to join:

  • You do not wish to sign a written consent form agreeing to take part
  • You have had surgery on the upper part of your abdomen in the past, or you have a hiatal hernia (where part of the stomach pushes up through the chest — confirm with trial site)
  • You are currently taking certain medications that can slow down stomach emptying, including opioid painkillers, proton pump inhibitors (such as omeprazole), tricyclic antidepressants, calcium channel blockers, antipsychotic medications, or lithium
  • You have a known allergy to a medicine called Itopride
  • You have a history of irregular heartbeat (heart arrhythmia) or an abnormal ECG (heart tracing)
  • You have a neurological condition such as Parkinson's disease or multiple sclerosis
  • You have serious liver or kidney problems

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +201154601505

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 April 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Residual gastric contents

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov